Clinical Trials Logo

Filter by:
NCT ID: NCT03198650 Not yet recruiting - Clinical trials for Advanced B-cell Malignancies

A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies

Start date: June 30, 2017
Phase: Phase 1
Study type: Interventional

This is a multicenter, open-label Phase 1 study of acalabrutinib, a selective and irreversible Bruton's tyrosine kinase inhibitor, in Japanese adult patients with advanced B-cell malignancies. This study is divided into 2 parts: Part 1 (dose-confirmation phase) and Part 2 (dose-expansion phase).

NCT ID: NCT03197935 Not yet recruiting - Clinical trials for Triple-negative Breast Cancer

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

IMpassion031
Start date: July 31, 2017
Phase: Phase 3
Study type: Interventional

This is a global Phase III, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy and safety of neoadjuvant treatment with atezolizumab (anti-programmed death-ligand 1 [anti-PD-L1] antibody) and nab-paclitaxel followed by doxorubicin and cyclophosphamide (nab-pac-AC), or placebo and nab-pac−AC in participants eligible for surgery with initial clinically assessed triple-negative breast cancer (TNBC).

NCT ID: NCT03196193 Recruiting - Clinical trials for Trochanteric Fracture of Femur

CM Asia Nail With AS2 Without AS2 (AS2 Study)

Start date: March 21, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare reduction positon maintenance rate at 3 weeks post-operatively between patients operated with Anterior Support Screw (AS2) and without AS2 technique in RCT setting. Total 240 cases(each arm 120 cases) will be enrolled at maximum 15sites, total study duration is 22months.

NCT ID: NCT03194646 Not yet recruiting - Leiomyoma Clinical Trials

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

ASTEROID 6
Start date: June 30, 2017
Phase: Phase 3
Study type: Interventional

The study is performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care

NCT ID: NCT03193034 Not yet recruiting - Osteoarthritis Clinical Trials

DSJ-2016-07 ATTUNE® Cementless CR RP Japan

Start date: June 26, 2017
Phase: Phase 4
Study type: Interventional

The primary objective is to investigate the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE® primary, cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score) in the Japanese patient population.

NCT ID: NCT03192943 Not yet recruiting - Advanced Cancer Clinical Trials

A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors

Start date: July 14, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability for the combination therapy of BMS-986205 and Nivolumab in patients with advanced tumors

NCT ID: NCT03191526 Recruiting - Clinical trials for HTLV-1 Associated Myelopathy

A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Start date: May 22, 2017
Phase: Phase 3
Study type: Interventional

The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.

NCT ID: NCT03189641 Recruiting - Clinical trials for Coronary Artery Disease

Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions

Start date: May 31, 2017
Phase: N/A
Study type: Interventional

The purpose of the this trial is to evaluate the clinical safety and efficacy of Cilostazol eluting stent system (CES-1) for the treatment of single de novo lesions in native coronary arteries.

NCT ID: NCT03188692 Recruiting - Immunization Clinical Trials

Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants

Start date: June 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of an intramuscular injection of BK1310 in healthy infants.

NCT ID: NCT03186131 Recruiting - Osteoporosis Clinical Trials

Efficacy of Oral Ibandronate in Osteoporosis

Start date: June 14, 2017
Phase: Phase 2
Study type: Interventional

There has been no comparative data between oral ibandronate and oral ibandronate plus active vitamin D